These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 36568247)

  • 1. Ferroptosis and triple-negative breast cancer: Potential therapeutic targets.
    Xu N; Li B; Liu Y; Yang C; Tang S; Cho WC; Huang Z
    Front Oncol; 2022; 12():1017041. PubMed ID: 36568247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Verification of a Prognostic Ferroptosis-Related Gene Model in Triple-Negative Breast Cancer.
    Wu S; Pan R; Lu J; Wu X; Xie J; Tang H; Li X
    Front Oncol; 2022; 12():896927. PubMed ID: 35719954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of the ferroptosis-related
    Yuan L; Liu J; Bao L; Qu H; Xiang J; Sun P
    Front Oncol; 2023; 13():1032364. PubMed ID: 37064114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and Validation of a Prognostic Risk Model for Triple-Negative Breast Cancer Based on Autophagy-Related Genes.
    Yan C; Liu Q; Jia R
    Front Oncol; 2022; 12():829045. PubMed ID: 35186763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of DNA Damage Repair Genes Involved in the Prognosis of Triple-Negative Breast Cancer Patients Based on Bioinformatics.
    Wang N; Gu Y; Chi J; Liu X; Xiong Y; Zhong C; Wang F; Wang X; Li L
    Front Genet; 2021; 12():721873. PubMed ID: 34408776
    [No Abstract]   [Full Text] [Related]  

  • 6. Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers.
    Liu Y; Teng L; Fu S; Wang G; Li Z; Ding C; Wang H; Bi L
    BMC Cancer; 2021 May; 21(1):644. PubMed ID: 34053447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma.
    Qin Y; Zhang D; Zhang H; Hou L; Wang Z; Yang L; Zhang M; Zhao G; Yao Q; Ling R; Zhang J
    Cancer Cell Int; 2022 Sep; 22(1):296. PubMed ID: 36175889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of potential key genes and pathways predicting pathogenesis and prognosis for triple-negative breast cancer.
    Lv X; He M; Zhao Y; Zhang L; Zhu W; Jiang L; Yan Y; Fan Y; Zhao H; Zhou S; Ma H; Sun Y; Li X; Xu H; Wei M
    Cancer Cell Int; 2019; 19():172. PubMed ID: 31297036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor 2 receptor is a key immune-related gene that is correlated with a poor prognosis in patients with triple-negative breast cancer: A bioinformatics analysis.
    Zhong Y; Ren X; Cao X; Xu Y; Song Y; Zhou Y; Mao F; Shen S; Wang Z; Sun Q
    Front Oncol; 2022; 12():871786. PubMed ID: 36330486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
    Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
    BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and validation of an individualized macrophage-related gene signature to predict overall survival in patients with triple negative breast cancer.
    Su P; Peng Z; Xu B; Yang B; Jin F
    PeerJ; 2021; 9():e12383. PubMed ID: 34900411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
    Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
    BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An iron metabolism and immune related gene signature for the prediction of clinical outcome and molecular characteristics of triple-negative breast cancer.
    Li XF; Fu WF; Zhang J; Song CG
    BMC Cancer; 2022 Jun; 22(1):619. PubMed ID: 35668369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a Group of Therapeutic Targets and Prognostic Biomarker for Triple Negative Breast Cancer.
    Li Y; Yang S; Qi L; Li Y; Wang X
    Adv Ther; 2024 Apr; 41(4):1621-1636. PubMed ID: 38421558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer.
    Yang X; Weng X; Yang Y; Zhang M; Xiu Y; Peng W; Liao X; Xu M; Sun Y; Liu X
    Aging (Albany NY); 2021 Aug; 13(15):19486-19509. PubMed ID: 34341184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four-lncRNA immune prognostic signature for triple-negative breast cancer Running title: Immune lncRNAs predict prognosis of TNBC.
    Li YX; Wang SM; Li CQ
    Math Biosci Eng; 2021 May; 18(4):3939-3956. PubMed ID: 34198419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated profiling uncovers prognostic, immunological, and pharmacogenomic features of ferroptosis in triple-negative breast cancer.
    Fang K; Xu Z; Jiang S; Yan C; Tang D; Huang Y
    Front Immunol; 2022; 13():985861. PubMed ID: 36505498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination therapy of isomucronulatol 7-O-beta-glucoside (IMG) and CEP-9722 targeting ferroptosis-related biomarkers in non-small cell lung cancer (NSCLC).
    Cui X; Liu C; Dong P; Liu C; Bai Y
    BMC Pulm Med; 2023 May; 23(1):162. PubMed ID: 37165402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Insights Into Triple-Negative Breast Cancer Prognosis by Comprehensive Characterization of Aberrant Alternative Splicing.
    Gong S; Song Z; Spezia-Lindner D; Meng F; Ruan T; Ying G; Lai C; Wu Q; Liang Y
    Front Genet; 2020; 11():534. PubMed ID: 32595697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a Ferroptosis Gene Set That Mediates the Prognosis of Squamous Cell Carcinoma of the Head and Neck.
    Li C; Wang X; Qin R; Zhong Z; Sun C
    Front Genet; 2021; 12():698040. PubMed ID: 34539737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.